Evidence before hype
Independent resource / about
About
Noctilume is an independent resource on ibogaine, anxiety, evidence, and safety.
It exists to distinguish early findings in complex populations from established treatment for anxiety disorders, and to make uncertainty, regulation, and serious safety considerations easier to see.
Independent by design
01 / Evidence
Claims are separated from the strength of support behind them.
02 / Context
Uncertainty, study limits, and regulation remain part of the picture.
03 / Safety
Serious risk considerations are not treated as a footnote.
Our editorial approach
Built for careful reading, not persuasion.
Noctilume organizes material around questions readers need to assess for themselves: what is known, what remains preliminary, where safety concerns sit, and which claims cannot be supported. The main resource on ibogaine and anxiety is structured to keep those distinctions visible rather than burying them beneath certainty.
Information is checked against research literature, study registries, and official sources where they are relevant. Trial records can be independently reviewed through ClinicalTrials.gov study listings, while the FDA’s drug information resources provide a useful official reference point for understanding the limits of medical claims and regulation.
Operating principles
A clear standard for every page.
Risk clarity
Plain language
Independence
Respect for uncertainty
What we cover
A navigable record of questions, not a promise of outcomes.
Research context
Pages distinguish early evidence, study design, and unanswered questions. For readers examining timing and persistence claims, the material on ibogaine half-life is framed as context rather than a conclusion.
Safety context
Risk is treated as central. The discussion of ibogaine risks and the page on fentanyl and ibogaine are organized to foreground serious considerations, not minimize them.
Common claims
Questions that circulate widely are addressed with careful wording, including whether ibogaine is addictive, without turning a complex question into a simple endorsement or dismissal.
Adjacent decisions
Readers can also find clearly separated context on ibogaine for withdrawal and on ibogaine and addiction, where population, setting, and uncertainty matter.
Who this is for
For adults seeking context they can examine.
Noctilume is intended for adults looking for careful, safety-conscious information about ibogaine, anxiety, research, and policy. It does not assume a reader is pursuing any particular path, and it does not ask readers to treat early findings as settled practice.
Its information pathways make the available material easier to navigate by question, while the pages retain the limitations and caveats that make a responsible interpretation possible. For an accessible general definition of evidence-based practice, the overview of evidence-based practice illustrates why research evidence, professional judgment, and individual context are not interchangeable.
“Clear information should make uncertainty easier to recognize—not easier to ignore.”
Independent by design
Information can be useful without becoming advice.
Noctilume is an independent editorial resource. It is not a clinic, medical provider, licensed treatment center, or legal authority. Its content is intended to support careful questions and does not provide medical or legal advice.